ADTX · As filed with the SEC

Aditxt cash flow statement, by quarter

The statement as Aditxt presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows (Unaudited) · USD

USD	Q1 2026 3 months ended Mar 31, 2026	Q4 2025^† 3 months ended Dec 31, 2025	Q3 2025^† 3 months ended Sep 30, 2025	Q2 2025^† 3 months ended Jun 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	(16,189,200)	(5,231,251)^†	(24,207,669)^†	(7,395,658)^†
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation	—	0^†	0^†	—
Stock-based compensation from asset purchase	—	0^†	0^†	0^†
Depreciation expense	47,882	66,807^†	66,966^†	67,048^†
Amortization of intangible assets	834	833^†	833^†	834^†
Amortization of debt discount - note payable	24,687	60,000^†	234,167^†	1,212,246^†
Amortization of debt discount - note receivable	—	(12,680)^†	(108,112)^†	—
Change in fair value of derivative liability	11,800,798	(228)^†	(162)^†	(980)^†
Change in fair value of Evofem warrants	(25,004)	(358,413)^†	(2,511,781)^†	—
Impairment of Evofem F-1 preferred stock	—	764,290^†	—	—
Impairment of fixed assets	32,275	—	—	—
Changes in operating assets and liabilities:
Accounts receivable	(11,974)	39,182^†	561^†	2,375^†
Prepaid expenses	294,310	(554,746)^†	0^†	0^†
Deposits	—	183,112^†	(28,752)^†	(36,100)^†
Inventory	9,289	798^†	1,045^†	1,440^†
Accounts payable and accrued expenses	(562,609)	(4,012,540)^†	931,660^†	3,327,433^†
Net cash used in operating activities	(4,578,712)	(9,245,673)^†	(2,344,554)^†	(2,384,737)^†
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of fixed assets	(10,379)	—	—	—
Net cash used in investing activities	(10,379)	(13,743)^†	0^†	—
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable, related party	—	0^†	185,000^†	—
Proceeds from notes and convertible notes payable, net of offering costs	2,855,000	(483,001)^†	170,000^†	—
Repayments of note payable, related party	—	(185,000)^†	0^†	(493,000)^†
Repayments of note payable	(1,428,921)	(2,421,248)^†	(265,874)^†	(1,147,782)^†
Common stock, preferred stock, and warrants issued for cash, net of issuance costs	603,261	16,789,941^†	2,560,449^†	4,608,763^†
Cash from subscription receivable	—	149,027^†	(149,027)^†	0^†
Redemptions of A-1 preferred stock	—	—	0^†	—
Redemptions of C-1 preferred stock	—	—	—	0^†
Redemptions of A-1 preferred stock	(369,996)	—	—	—
Net cash provided by financing activities	1,659,344	12,294,974^†	2,183,916^†	4,657,000^†
NET DECREASE IN CASH	(2,929,747)	—	—	(152,737)^†
CASH AT BEGINNING OF PERIOD	3,198,599	163,041	323,679	476,416
CASH AT END OF PERIOD	268,852	3,198,599	163,041	323,679
Supplemental cash flow information:
Cash paid for interest	152,965	1,201,042^†	0^†	0^†
NONCASH INVESTING AND FINANCING ACTIVITIES:
Accrued interest rolled into notes payable	—	0^†	—	—
Derivative liability from conversion feature on warrants	13,736,777	—	—	—
Derivative liability from conversion feature on preferred stock	9,913,157	—	—	—
ELOC payable	—	0^†	(302,034)^†	0^†
Series C-1 redemption payable	—	(843,011)^†	(1,521,536)^†	1,354,678^†
ELOC commitment fee stock payable	—	0^†	0^†	0^†
Loan in escrow	—	0^†	0^†	—
Reclassification of series A-1 preferred shares to liabilities	369,996	(561,603)^†	561,603^†	—
Conversion of Series A-1 to common stock	20,000,000	—	—	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.